Search Results - "Millard, Katrina G."
-
1
Evolution of antibody immunity to SARS-CoV-2
Published in Nature (London) (25-03-2021)“…Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has infected 78 million individuals and is responsible for over 1.7 million deaths to date…”
Get full text
Journal Article -
2
Naturally enhanced neutralizing breadth against SARS-CoV-2 one year after infection
Published in Nature (London) (15-07-2021)“…More than one year after its inception, the coronavirus disease 2019 (COVID-19) pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)…”
Get full text
Journal Article -
3
Increased memory B cell potency and breadth after a SARS-CoV-2 mRNA boost
Published in Nature (London) (07-07-2022)“…The Omicron variant of SARS-CoV-2 infected many vaccinated and convalescent individuals 1 – 3 . Despite the reduced protection from infection, individuals who…”
Get full text
Journal Article -
4
Anti-SARS-CoV-2 receptor-binding domain antibody evolution after mRNA vaccination
Published in Nature (London) (16-12-2021)“…Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection produces B cell responses that continue to evolve for at least a year. During that time,…”
Get full text
Journal Article -
5
Antibody feedback regulates immune memory after SARS-CoV-2 mRNA vaccination
Published in Nature (London) (26-01-2023)“…Feedback inhibition of humoral immunity by antibodies was first documented in 1909 1 . Subsequent studies showed that, depending on the context, antibodies can…”
Get full text
Journal Article -
6
Memory B cell responses to Omicron subvariants after SARS-CoV-2 mRNA breakthrough infection in humans
Published in The Journal of experimental medicine (05-12-2022)“…Individuals who receive a third mRNA vaccine dose show enhanced protection against severe COVID-19, but little is known about the impact of breakthrough…”
Get full text
Journal Article -
7
Antibody evolution to SARS-CoV-2 after single-dose Ad26.COV2.S vaccine in humans
Published in The Journal of experimental medicine (01-08-2022)“…The single-dose Ad.26.COV.2 (Janssen) vaccine elicits lower levels of neutralizing antibodies and shows more limited efficacy in protection against infection…”
Get full text
Journal Article -
8
mRNA vaccine-elicited antibodies to SARS-CoV-2 and circulating variants
Published in Nature (London) (22-04-2021)“…Here we report on the antibody and memory B cell responses of a cohort of 20 volunteers who received the Moderna (mRNA-1273) or Pfizer–BioNTech (BNT162b2)…”
Get full text
Journal Article -
9
Structures of Human Antibodies Bound to SARS-CoV-2 Spike Reveal Common Epitopes and Recurrent Features of Antibodies
Published in Cell (20-08-2020)“…Neutralizing antibody responses to coronaviruses mainly target the receptor-binding domain (RBD) of the trimeric spike. Here, we characterized polyclonal…”
Get full text
Journal Article -
10
Affinity maturation of SARS-CoV-2 neutralizing antibodies confers potency, breadth, and resilience to viral escape mutations
Published in Immunity (Cambridge, Mass.) (10-08-2021)“…Antibodies elicited by infection accumulate somatic mutations in germinal centers that can increase affinity for cognate antigens. We analyzed 6 independent…”
Get full text
Journal Article -
11
Prolonged viral suppression with anti-HIV-1 antibody therapy
Published in Nature (London) (09-06-2022)“…HIV-1 infection remains a public health problem with no cure. Anti-retroviral therapy (ART) is effective but requires lifelong drug administration owing to a…”
Get full text
Journal Article -
12
Memory B cell development elicited by mRNA booster vaccinations in the elderly
Published in The Journal of experimental medicine (04-09-2023)“…Despite mRNA vaccination, elderly individuals remain especially vulnerable to severe consequences of SARS-CoV-2 infection. Here, we compare the memory B cell…”
Get full text
Journal Article -
13
Humoral immunity to SARS-CoV-2 elicited by combination COVID-19 vaccination regimens
Published in The Journal of experimental medicine (03-10-2022)“…The SARS-CoV-2 pandemic prompted a global vaccination effort and the development of numerous COVID-19 vaccines at an unprecedented scale and pace. As a result,…”
Get full text
Journal Article -
14
Effect of 3BNC117 and romidepsin on the HIV-1 reservoir in people taking suppressive antiretroviral therapy (ROADMAP): a randomised, open-label, phase 2A trial
Published in The Lancet. Microbe (01-03-2022)“…The administration of broadly neutralising anti-HIV-1 antibodies before latency reversal could facilitate elimination of HIV-1-infected CD4 T cells. We tested…”
Get full text
Journal Article -
15
Severe Acute Respiratory Syndrome Coronavirus 2 Neutralization After Messenger RNA Vaccination and Variant Breakthrough Infection
Published in Open forum infectious diseases (01-07-2022)“…Abstract The emergence of severe acute respiratory syndrome coronavirus 2 variants that have greater transmissibility and resistance to neutralizing antibodies…”
Get full text
Journal Article -
16
Convergent antibody responses to SARS-CoV-2 in convalescent individuals
Published in Nature (London) (20-08-2020)“…During the coronavirus disease-2019 (COVID-19) pandemic, severe acute respiratory syndrome-related coronavirus-2 (SARS-CoV-2) has led to the infection of…”
Get full text
Journal Article -
17